openPR Logo
Press release

Radiopharmaceuticals Market Size is projected to reach US$ 8.8 billion by 2032, growing at a CAGR of 7.4% | Top Key Players are Bayer AG, Cardinal Health, Eckert & Ziegler, GE Healthcare and Others

03-27-2023 05:35 PM CET | Health & Medicine

Press release from: Extrapolate

Radiopharmaceuticals Market

Radiopharmaceuticals Market

The global Radiopharmaceuticals Market size was worth around USD 4.3 billion in 2022 and is anticipated to grow to around USD 8.8 billion by 2032 at a CAGR of around 7.4% between 2023 and 2032.

Download a Sample PDF of the Report @ https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/radiopharmaceuticals-market/87448

Market Overview of Radiopharmaceuticals:
The use of radiopharmaceuticals is on the rise due to the increasing prevalence of chronic diseases, neurological problems, and cancer, among others. Radiopharmaceuticals are small radioactive isotopes that target specific body tissues and organs, making them useful for the diagnosis and treatment of various disorders. In recent years, there has been a growing awareness of the early diagnosis of chronic diseases, which has led to an increased demand for radiopharmaceuticals. Technological advancements in nuclear imaging have also contributed to the growth of the radiopharmaceutical market, as hybrid devices have become more efficient and effective than standalone devices.

Radiopharmaceuticals have several advantages over conventional radiotherapy, including fewer side effects and the ability to treat individual tumors and metastatic cancer spread throughout the body. This has made them increasingly popular, especially in oncology. In addition, radiopharmaceuticals combined with newer, more sensitive, and specific scanning techniques enable doctors to perform pre-treatment, improving patient outcomes.

Preparation and dispensing problems associated with radiopharmaceuticals also pose a challenge to market growth. The chemical reactions involved in preparing radiopharmaceuticals can generate undesired radiochemical impurities, and radiolysis effects may occur with high-intensity radiations, leading to undesired impurities. These issues can ultimately interfere with diagnostic interpretation and limit the adoption of radiopharmaceuticals.

Leading Players operating in the Radiopharmaceuticals Market are:
• Bayer AG
• Cardinal Health
• Eckert & Ziegler
• GE Healthcare
• Jubilant Pharma Limited
• NorthStar Medical Radioisotopes, LLC
• NorthStar Medical Radioisotopes, LLC
• Novartis AG
• NTP Radioisotopes SOC Ltd
• Siemens Healthineers
• Telix Pharmaceuticals Limited

SEGMENTATION

By Product
• Technetium-99
• Fluorine-18
• Iodine-131
• Leutetium-177
• Yttrium-90

By Type
• Diagnostic Nuclear Medicine
• Therapeutic Nuclear Medicine

By Application
• Neurology
• Cardiology
• Oncology
• Others

By End-user
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Cancer Research Institutes

Have an Inquiry? Get in Touch with us @ https://www.extrapolate.com/enquire/healthcare-medical-devices-biotechnology/radiopharmaceuticals-market/87448

By Region
• North America
• Europe
• Asia
• Latin America
• The Middle East and Africa

Why Purchase the Report?
• The report includes information such as market dynamics scenario, opportunities and challenges during the forecast period
• Identify the key regulations prevailing in the market and understand their impact on the market over the forecast period
• Regional, sub-regional, and country-level data include the demand and supply forces along with their influence on the market.
• The competitive landscape comprises a share of key players, offering products, relevant financial information, recent developments, SWOT analysis, and strategies.
• Understand the current market scenario and viability of the global market over the forecast period.

Browse Full Report@ https://www.extrapolate.com/healthcare-medical-devices-biotechnology/radiopharmaceuticals-market/87448

Some of the key questions answered in this report:
• What can we estimate about the anticipated growth rates and also the global Radiopharmaceuticals Market industry size by 2032?
• What will happen in the coming existing and emerging markets?
• What will the market development pace of market?
• Which are the five top players in the Radiopharmaceuticals Market?
• How will the Radiopharmaceuticals Market change in the upcoming years?

KEY INDUSTRY DEVELOPMENTS:
In January 2023: NorthStar Medical Radioisotopes, LLC, and Inhibrx, Inc. entered into a collaboration agreement for the development and production of new radiopharmaceuticals for cancer treatment. The collaboration aims to support a specified number of Inhibrx's new biological products by providing the supply of Ac-225 and access to integrated radiopharmaceutical contract development and manufacturing organization (CDMO) services.

TABLE OF CONTENTS-
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact on Radiopharmaceuticals Market
Chapter 5. Global Radiopharmaceuticals Market Overview, By Product, 2018 - 2032(USD Million)
---------Continued

Browse Complete TOC: https://www.extrapolate.com/toc/healthcare-medical-devices-biotechnology/radiopharmaceuticals-market/87448

Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: talk@extrapolate.com
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog

About Extrapolate
Extrapolate is a Global Market Research, Advisory and Consulting firm which works closely with Industry experts from various industries to bring the latest and most accurate research reports.

In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets - not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Size is projected to reach US$ 8.8 billion by 2032, growing at a CAGR of 7.4% | Top Key Players are Bayer AG, Cardinal Health, Eckert & Ziegler, GE Healthcare and Others here

News-ID: 2990678 • Views:

More Releases from Extrapolate

ChatGPT: Your Secret Weapon for Dominating Search Rankings through AI-powered Content Optimization
ChatGPT: Your Secret Weapon for Dominating Search Rankings through AI-powered Co …
The ability to do efficient keyword research and content optimization is now essential for anyone looking to succeed online in the information-driven digital age. But fear not; ChatGPT is a formidable friend at our disposal. The way we approach keyword research and content creation is about to change due to this amazing language model that OpenAI created. Let's look into how to use ChatGPT to improve content optimization tactics, and
Lead Acid Battery Market Size is Set to Fly High Growth in Years to Come | Leoch International Technology, CSB Battery, Chloride Batteries, Nipress, and Others
Lead Acid Battery Market Size is Set to Fly High Growth in Years to Come | Leoch …
Market Overview Lead-acid batteries are the oldest type of rechargeable battery and are commonly used in a variety of applications, including automobiles, boats, uninterruptible power supplies (UPS), and backup power for telecommunications and computer systems. These batteries consist of lead plates submerged in an electrolyte solution of sulfuric acid and water. During charging, electrical energy is converted into chemical energy, which is stored in the battery as lead sulfate. When the battery
Onshore Wind Energy Market Size Focus on Emerging Technologies, Top Countries Data Analyses, Growth Estimate, Business Development and Forecast Till 2028
Onshore Wind Energy Market Size Focus on Emerging Technologies, Top Countries Da …
Market Overview The Global Onshore Wind Energy Market Size was estimated at USD 554909.73 million in 2021 and is projected to reach USD 2356796.43 million by 2028, exhibiting a CAGR of 22.95% during the forecast period. Onshore wind energy is a form of renewable energy that involves generating electricity by harnessing the power of wind on land. This is typically done using wind turbines, which convert the kinetic energy of the wind
Vegetable Seeds Market is expected to witness a substantial growth of around USD 16.38 billion by 2032
Vegetable Seeds Market is expected to witness a substantial growth of around USD …
The global Vegetable seeds market size was valued at approximately USD 8.72 billion in 2022 and is expected to witness a substantial growth of around USD 16.38 billion by 2032 at a CAGR of approximately 6.51% during the period from 2023 to 2032.The vegetable seeds market refers to the global trade of seeds used for growing different types of vegetables, including but not limited to tomatoes, onions, cucumbers, carrots, and

All 5 Releases


More Releases for Radiopharmaceuticals

Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842 This latest report researches the industry structure, sales, revenue, price and
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a